Glycogen synthase kinase‐3β and tau genes interact in Alzheimer's disease

We examined the epistatic effect between haplotypes of glycogen synthase kinase‐3β (GSK3B) gene and microtubule‐associated protein Tau (MAPT) gene in Alzheimer's disease (AD).

[1]  D. Benson,et al.  Alzheimer's disease and Parkinson's disease , 1988, Neurology.

[2]  Simon Lovestone,et al.  Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells , 1994, Current Biology.

[3]  Hans Clevers,et al.  Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis , 1998, Nature.

[4]  I Litvan,et al.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.

[5]  P. Schofield,et al.  Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene , 2000 .

[6]  S. Lovestone,et al.  Does dysregulation of the Notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer's disease? , 2000, Molecular medicine today.

[7]  M. Bullido,et al.  A polymorphism in the tau gene associated with risk for Alzheimer's disease , 2000, Neuroscience Letters.

[8]  R. Petersen,et al.  No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease , 2000, Neuroscience Letters.

[9]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[10]  S. Lovestone,et al.  The microtubule associated protein Tau gene and Alzheimer's disease – an association study and meta-analysis , 2001, Neuroscience Letters.

[11]  A. McMahon,et al.  Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. , 2001, Development.

[12]  Edward H. Koo,et al.  Presenilin Couples the Paired Phosphorylation of β-Catenin Independent of Axin Implications for β-Catenin Activation in Tumorigenesis , 2002, Cell.

[13]  Peter H. Westfall,et al.  Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals , 2002, Human Heredity.

[14]  B. de Strooper,et al.  Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. , 2002, Cell.

[15]  N. Shahani,et al.  Functions and malfunctions of the tau proteins , 2002, Cellular and Molecular Life Sciences CMLS.

[16]  L. Waite,et al.  A 6-Year Study of Cognition and Spatial Function in the Demented and Non-Demented Elderly: The Sydney Older Persons Study , 2003, Dementia and Geriatric Cognitive Disorders.

[17]  C. Walsh,et al.  Increased neuronal production, enlarged forebrains and cytoarchitectural distortions in beta-catenin overexpressing transgenic mice. , 2003, Cerebral cortex.

[18]  K. Marder,et al.  The Saitohin ‘Q7R’ polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts , 2003, Neuroscience Letters.

[19]  Jason H. Moore,et al.  The Ubiquitous Nature of Epistasis in Determining Susceptibility to Common Human Diseases , 2003, Human Heredity.

[20]  P. Heutink,et al.  Chasing genes in Alzheimer’s and Parkinson’s disease , 2004, Human Genetics.

[21]  P. Hobson,et al.  Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom , 2004, Movement disorders : official journal of the Movement Disorder Society.

[22]  A. Singleton,et al.  The tau H2 haplotype is almost exclusively Caucasian in origin , 2004, Neuroscience Letters.

[23]  Erdahl T. Teber,et al.  Tau haplotypes regulate transcription and are associated with Parkinson's disease , 2004, Annals of neurology.

[24]  R. Jope,et al.  The glamour and gloom of glycogen synthase kinase-3. , 2004, Trends in biochemical sciences.

[25]  T. Asada,et al.  Association between Tau polymorphism and male early-onset Alzheimer's disease , 2004, Neuroreport.

[26]  Peter R Schofield,et al.  GSK3B polymorphisms alter transcription and splicing in Parkinson's disease , 2005, Annals of neurology.

[27]  A J Lees,et al.  Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration , 2005, Journal of Medical Genetics.

[28]  Sasha F. Levy,et al.  Three- and Four-repeat Tau Regulate the Dynamic Instability of Two Distinct Microtubule Subpopulations in Qualitatively Different Manners , 2005, Journal of Biological Chemistry.

[29]  S. Stamm,et al.  Tau Exons 2 and 10, Which Are Misregulated in Neurodegenerative Diseases, Are Partly Regulated by Silencers Which Bind a SRp30c·SRp55 Complex That Either Recruits or Antagonizes htra2β1* , 2005, Journal of Biological Chemistry.

[30]  A M Pittman,et al.  The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. , 2005, Human molecular genetics.

[31]  M. Esiri,et al.  Haplotype-specific expression of exon 10 at the human MAPT locus. , 2006, Human molecular genetics.

[32]  H. Chiu,et al.  Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population , 2006, International Psychogeriatrics.

[33]  O. Combarros,et al.  Association between Glycogen Synthase Kinase-3β Genetic Polymorphism and Late-Onset Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.

[34]  R. Jope,et al.  Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics , 2007, Neurochemical Research.

[35]  George M. Church,et al.  Single molecule profiling of tau gene expression in Alzheimer’s disease , 2007, Journal of neurochemistry.

[36]  Huaxi Xu,et al.  Phosphorylation of tau antagonizes apoptosis by stabilizing β-catenin, a mechanism involved in Alzheimer's neurodegeneration , 2007, Proceedings of the National Academy of Sciences.

[37]  K. Jellinger.  Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study. , 2007, Journal of neural transmission. Supplementum.

[38]  A. Myers,et al.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts , 2007, Neurobiology of Disease.

[39]  M. Owen,et al.  Candidate gene association study of insulin signaling genes and Alzheimer's disease: Evidence for SOS2, PCK1, and PPARγ as susceptibility loci , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[40]  Hans Förstl,et al.  Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease , 2007, Molecular Psychiatry.